美國Alfa 瘦肉精監測卡

廣州健侖生物科技有限公司

我司長期供應瘦肉精三聯檢測卡，本產品用于快速檢測動物尿樣、組織和飼料中鹽酸克倫特羅、萊克多巴胺、沙丁胺醇殘留，整個檢測過程只需要3-5分鐘左右，具有操作簡單，方便快捷，靈敏度高特異性強等特點。

瘦肉精檢測試劑進口品牌：美國Alfa、美國US

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

歡迎咨詢

歡迎咨詢2042552662

瘦肉精檢測試劑盒、瘦肉精檢測試劑、瘦肉精檢測卡、瘦肉精檢測試紙、瘦肉精快速檢測卡、瘦肉精三聯檢測卡、鹽酸克倫特羅檢測卡、萊克多巴胺檢測卡、沙丁胺醇檢測卡

【瘦肉精的危害】

“瘦肉精”進入動物體內后主要分布于肝臟。肌肉中含量較肝臟低很多。人攝入后在體內存留時間較長，其不良反應主要有：可引起心率加速，特別是原有心律失常的病例更易發生心臟反應，可見心室早搏、ST段與T波幅壓低，還會發出肌肉震顫，引發四肢、面頸部骨骼肌震顫，尤其是交感神經功能亢進的病例更易發生。此外，還可引起代謝紊亂、血鉀降低，引起心慌、肌肉震顫、頭痛以及臉部潮紅等。對心率失常、高血壓、青光眼、糖尿病、甲狀腺機能亢進等疾病的患者有較大危害。

美國Alfa 瘦肉精監測卡

【產品簡介】

本產品為克倫特羅-萊克多巴胺-沙丁胺醇三合一膠體金快速檢測卡，用于定性檢測豬、牛、羊尿液、組織和飼料中的瘦肉精殘留，整個檢測過程只需要3-5分鐘左右。

【檢測限】

克倫特羅3ng/ml（3ppb），萊克多巴胺3ng/ml（3ppb），沙丁胺醇3ng/ml（3ppb）

【產品組成】

克倫特羅-萊克多巴胺-沙丁胺醇三合一膠體金快速檢測卡（40T/盒）

滴管（1個/袋）、干燥劑（1片/袋）

【樣品處理】

用干燥、潔凈的離心管或適當容器采集50ml左右尿液。如果不立即檢測，待檢樣本在2-8℃存放，可保存24小時，注意避免腐壞造成失效或污染。出現陽性結果應按法定程序分瓶封裝樣品用于確證法檢測。

【使用步驟】

1、測試前先完整閱讀說明書，使用前將檢測卡和待檢樣本溶液恢復至室溫4～30℃。

2、從原包裝袋中取出檢測卡，打開后請在一個小時內盡快地使用。

3、將檢測卡平放，用滴管吸取待檢樣品溶液，緩慢垂直滴加2-3滴于加樣孔中，加樣后開始計時。

4、結果應在3-5分鐘時讀取，其他時間判讀無效，根據示意圖判定結果。

【結果判斷】

1. 陰性（-）：兩條紫紅色條帶出現。表示樣品中不含有瘦肉精或其濃度低于檢測限。
2. 陽性（+）：檢測T線無顯色，則表示樣品中瘦肉精濃度高于檢測限。

1. 無效：未出現質控C線，表明操作過程不正確或檢測卡已失效。

【注意事項】

1、檢測卡請在保質期內一次性使用；

2、檢測時避免陽光直射和電風扇直吹；

3、盡量不要觸摸檢測卡中央的白色膜面；

4、采樣滴管不可混用，以免交叉污染；

5、如果待檢樣本出現沉淀或渾濁物，請離心后再檢測；

6、試驗遇到的任何問題，請與供應商。

【儲存及有效期】

原包裝應儲存于4～40℃，陰涼避光干燥處，切勿冷凍；有效期24個月。有效期及批號見外包裝。

美國Alfa

2009年，隨著醫藥行業專項整治可能帶來的市場規范化程度提升、新醫改方案帶來市場擴容機會、新上市產品的增加、藥品終端需求活躍以及新一輪投資熱潮等眾多有利因素將保證中國醫藥行業繼續快速增長。但隨著金融危機的蔓延和世界經濟的減速，中國醫藥外貿面臨的形勢更加嚴峻。2009年有可能是進入新世紀以來zui為困難的一年。但是由于中國醫藥行業的特點以及新醫改對內需的拉動作用，中國醫藥進出口總額有望繼續保持一定的增長。“變壓力為動力、化挑戰為機遇”將成為2009年中國醫藥外貿發展的主旋律。
藥水
藥水
展望未來，中國醫藥行業景氣才剛剛開始，未來提升空間巨大。醫藥產業進入新醫改牽引下的新一輪有序發展期。未來新醫改方案將對中國醫藥行業的市場結構、產業結構、產品結構等方面產生深刻的影響，到2010年，醫改帶來的藥品增量至少在1000億以上，加上行業自然增長部分，預計未來3-5年醫藥行業的年增長率不會低于20%。
中藥情景
整個中藥材產需及市場供求關系將發生以下變化：
1、生產相對穩定，貨源緊中有松。隨著我國農村產業結構初見成效，糧棉總量調減，優質品種增加，市價略有回升，各種經濟作物亦按照市場需求進行調整，作為農付產品的中藥材，自1997年下半年出現總體減少，價格一路下滑，至今已持續三年多,由于藥價偏低，藥材生產大多微利或低于生產成本，使藥農的種植積極性大打折扣。同時藥農痛定思痛，吸取教訓，開始面向市場有的放失發展生產，壓縮那些滯銷積壓的品種面積，擴大市場緊俏*的品種生產面積，經過幾年的市場調節與生產調整，藥材市場的供求關系開始趨向合理，據有關資料顯示，近一二年全國家種面積一直保持在37-40萬公頃之間波動，尤其山東、江蘇、陜西、云南、貴州、安徽、山西等省份發展迅猛。預計年內常用大宗品種，如桔梗、板蘭根、生地黃、白芷、牛膝、玄參、白藥、太子參、紅花、川芎、黨參、北沙參等品種因受前幾年市場“高炒”價格跌至近幾年來的谷底的影響，生產出現不同程度的違禁品，市場行情正處于由低向高運行的轉折點，隨著歷年庫存的消耗，這些品種價格可望發生逆轉。少部分多年生品種如山茱萸、黃連等品種因多種因素影響,供求矛盾尚難好轉,貨源將日益緊缺。大茴、小良姜、山萘、丁香、草果等藥食兼用的香料藥材品種，因其價格偏高，按市場規律 。

美國Alfa

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、食品安全、化妝品檢測、藥物濫用檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

想了解更多的產品及服務請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室

In 2009, with the standardization of the market brought by special rectification by the pharmaceutical industry, the new healthcare reform program will bring about opportunities for expansion of the market. The favorable factors such as the increase of new listings, the active demand of pharmaceutical terminals and the new round of investment boom will ensure that China The pharmaceutical industry continues to grow rapidly. However, with the spread of the financial crisis and the slowdown of the world economy, the situation facing China's pharmaceutical foreign trade is even more severe. 2009 may be the most difficult year since entering the new century. However, due to the characteristics of China's pharmaceutical industry and the stimulating effect of the new medical reform on domestic demand, the total volume of China's pharmaceutical exports and imports is expected to continue to grow at a certain rate. "Transforming pressure into motivation and turning challenges into opportunities" will become the main theme of the development of China's pharmaceutical foreign trade in 2009.
Potion
Potion
Looking to the future, the prosperity of China's pharmaceutical industry has just begun, huge room for improvement in the future. The pharmaceutical industry has entered a new round of orderly development under the guidance of new medical reform. The new medical reform plan in the future will have a profound impact on the market structure, industrial structure and product structure of China's pharmaceutical industry. By 2010, the increase in pharmaceuticals brought by medical reform will be at least 100 billion or more. Coupled with the natural growth of the industry, The next three to five years the pharmaceutical industry will not be less than 20% annual growth rate.
Chinese scene
The entire Chinese herbal medicine production and demand and market supply and demand will occur the following changes:
1, the production is relatively stable, tight supply tight. With the initial success of China's rural industrial structure, the total amount of grain and cotton decreased, the quality of varieties increased, the market price rebounded slightly, and various cash crops were also adjusted according to market demand. As the traditional Chinese medicines for agricultural products, since the second half of 1997 As a whole, the prices have been decreasing and the price has been falling all the way. It has lasted for more than three years. Due to the low price of medicines, the production of medicinal herbs is mostly at a low profit or below the production cost, which greatly reduces the enthusiasm of the farmers. At the same time, medicine and agricultural science and thinking pain, learn a lesson, some market-oriented start to lose the development of production, compression of those who sell off the backlog of varieties of area, expanding the market tight and profitable production area, after years of market regulation and production adjustment, medicine market supply and demand The trend is reasonable. According to relevant statistics, the total area of ??family-owned species in the country has fluctuated between 3,700,000 and 4,000 hectares in recent one or two years. In particular, the provinces of Shandong, Jiangsu, Shaanxi, Yunnan, Guizhou, Anhui and Shanxi have been developing rapidly. It is estimated that the varieties commonly used during the year such as Campanulaceae, Radix, Radix Rehmanniae, Angelica, Achyranthes, Scrophulariaceae, Baiyao, heterophylla, safflower, Chuanxiong, Codonopsis, Pak Sanshen varieties due to the market a few years ago, "speculation" price Fell to the bottom in recent years, the impact of the production of varying degrees of contraband, the market is at a turning point from low to high, with the depletion of inventory over the years, these varieties are expected to reverse the price. A small number of perennial varieties such as dogwood, berberine and other varieties due to many factors, the supply and demand is still difficult to improve the contradiction between supply will increasingly scarce. Fennel, small galangal, naphthalene, cloves, grass and other medicinal herbs and spices spices, because of their high prices, according to market rules.